The Big Fix

The Big Fix investigates fraud and corruption in the generic drug industry, focusing on the largest generic drug manufacturer in the world, Ranbaxy. Through interviews and extensive documentation, author Katharine Eban traces the actions of company executives, FDA regulators, and whistleblowers over multiple decades. The narrative follows a FDA investigator who uncovers troubling practices at overseas manufacturing facilities that produce drugs for the U.S. market. Parallel storylines track internal company dynamics and the efforts of individuals who tried to expose quality control issues and falsified data. The book details the complex web of international pharmaceutical manufacturing, regulatory oversight, and market pressures that impact drug safety and efficacy. Eban reconstructs key events through corporate documents, regulatory filings, and firsthand accounts from industry insiders. This work raises fundamental questions about pharmaceutical regulation and the true cost of cheap generic medications in a globalized economy. The investigation reveals tensions between profit motives and public health, while examining the systems meant to protect consumers.

Readers found the book reveals extensive documentation about pharmaceutical manufacturing problems in India and China, backed by years of investigative reporting. Many noted the clear explanation of complex regulatory and supply chain issues. Readers appreciated: - Detailed interviews with whistleblowers and FDA investigators - Clear breakdown of technical pharmaceutical concepts - Specific examples of data manipulation and fraud - Evidence-based approach without sensationalism Main criticisms: - Can be repetitive with similar examples - Technical sections challenge some general readers - Some found the scope too narrow, wanted broader industry coverage Ratings: Goodreads: 4.25/5 (413 ratings) Amazon: 4.5/5 (165 ratings) Multiple readers called it "eye-opening" regarding drug quality issues. One reviewer noted it "reads like a thriller but it's all true." Several criticized the book's focus on Indian manufacturers while not fully exploring other countries' roles. A few readers mentioned difficulty following the large cast of characters and companies.

Bad Blood by John Carreyrou The investigation of Theranos exposes fraud, deception, and the dangers of Silicon Valley's startup culture in healthcare technology.

Empire of Pain by Patrick Radden Keefe The story tracks the Sackler family's role in the opioid crisis through their company Purdue Pharma and the marketing of OxyContin.

Bottle of Lies by Katherine Eban This investigation reveals the truth about generic drug manufacturing and FDA oversight in overseas facilities.

The Poison Squad by Deborah Blum The book chronicles the birth of food safety regulations through the work of chemist Harvey Washington Wiley and his fights against dangerous food additives.

American Overdose by Chris McGreal The narrative traces the origins and expansion of America's opioid epidemic through pharmaceutical companies, doctors, and government agencies.

🔬 Author Katharine Eban spent five years investigating the generic drug industry, conducting over 20,000 interviews and reviewing thousands of confidential FDA documents. 💊 The book reveals how one FDA inspector, Peter Baker, discovered that 40% of all generic drugs were failing their quality tests, yet companies were manipulating data to hide these failures. 🏭 Many of the factories described in the book that manufacture generic drugs for the U.S. market are located in India and China, where labor costs are roughly one-tenth of those in America. 📋 The investigation exposed how some companies maintained two sets of books: official records for FDA inspectors and "unofficial" records showing actual test results and production details. 🌍 The findings in "The Big Fix" led to congressional hearings and influenced FDA policy changes regarding overseas drug manufacturing inspections and quality control measures.